bpV(bipy) 5 mg | >98%
AdipoGen Life Sciences
Potent protein phosphotyrosine phosphatase inhibitor. Insulin mimetic in vitro and in vivo. PTEN inhibitor.
More Information Supplier Page
Potent protein phosphotyrosine phosphatase inhibitor. Insulin mimetic in vitro and in vivo. PTEN inhibitor.
More Information Supplier PagePotent histone acetyltransferase (HAT) inhibitor. Antibacterial. SUMOylation inhibitor. Lipoxygenase inhibitor. NF-kappaB inhibitor. Anti-tumor compound. Anti-inflammatory. Apoptosis inducer. Antiproliferative.
More Information Supplier PagePotent histone acetyltransferase (HAT) inhibitor. Antibacterial. SUMOylation inhibitor. Lipoxygenase inhibitor. NF-kappaB inhibitor. Anti-tumor compound. Anti-inflammatory. Apoptosis inducer. Antiproliferative.
More Information Supplier PagePotent and selective TRPV1 antagonist. Glutamatergic synaptic transmission inhibitor.
More Information Supplier PagePotent and selective TRPV1 antagonist. Glutamatergic synaptic transmission inhibitor.
More Information Supplier PageSelective PPARgamma agonist (EC50=3 µM). Hypoglycemic agent. Angiogenesis inhibitor. Anti-inflammatory. Apoptosis inducer.
More Information Supplier PageSelective PPARgamma agonist (EC50=3 µM). Hypoglycemic agent. Angiogenesis inhibitor. Anti-inflammatory. Apoptosis inducer.
More Information Supplier PageSelective PPARgamma agonist (EC50=3 µM). Hypoglycemic agent. Angiogenesis inhibitor. Anti-inflammatory. Apoptosis inducer.
More Information Supplier PageHDAC 1 inhibitor. Antitumor compound. Antiproliferative. TGF-beta type II receptor inducer. Apoptosis inducer. Anti-inflammatory. Angiogenesis inhibitor. Review. Promotes either self-renewal or differentiation of embryonic stem cells.
More Information Supplier PageHDAC 1 inhibitor. Antitumor compound. Antiproliferative. TGF-beta type II receptor inducer. Apoptosis inducer. Anti-inflammatory. Angiogenesis inhibitor. Review. Promotes either self-renewal or differentiation of embryonic stem cells.
More Information Supplier Page